These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10807546)

  • 1. Disparity between association and linkage analysis for HNF1A G319S in type 2 diabetes in Canadian Oji-Cree.
    Hegele RA; Hanley AJ; Zinman B; Harris SB; Anderson CM
    J Hum Genet; 2000; 45(3):184-7. PubMed ID: 10807546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism between mutant HNF1A and the metabolic syndrome in Oji-Cree Type 2 diabetes.
    Pollex RL; Hanley AJ; Zinman B; Harris SB; Khan HM; Hegele RA
    Diabet Med; 2005 Nov; 22(11):1510-5. PubMed ID: 16241915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genetic associations with hypertriglyceridemic waist in a Canadian aboriginal population.
    Pollex RL; Hanley AJ; Zinman B; Harris SB; Hegele RA
    Int J Obes (Lond); 2006 Mar; 30(3):484-91. PubMed ID: 16276364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide scanning for type 2 diabetes susceptibility in Canadian Oji-Cree, using 190 microsatellite markers.
    Hegele RA; Sun F; Harris SB; Anderson C; Hanley AJ; Zinman B
    J Hum Genet; 1999; 44(1):10-4. PubMed ID: 9929969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The private hepatocyte nuclear factor-1alpha G319S variant is associated with plasma lipoprotein variation in Canadian Oji-Cree.
    Hegele RA; Cao H; Harris SB; Hanley AJ; Zinman B; Connelly PW
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):217-22. PubMed ID: 10634821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree.
    Hegele RA; Cao H; Harris SB; Hanley AJ; Zinman B
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1077-82. PubMed ID: 10084598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree.
    Hegele RA; Cao H; Harris SB; Zinman B; Hanley AJ; Anderson CM
    J Clin Endocrinol Metab; 2000 May; 85(5):2014-9. PubMed ID: 10843190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genes, environment and Oji-Cree type 2 diabetes.
    Hegele RA; Zinman B; Hanley AJ; Harris SB; Barrett PH; Cao H
    Clin Biochem; 2003 May; 36(3):163-70. PubMed ID: 12726923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community.
    Triggs-Raine BL; Kirkpatrick RD; Kelly SL; Norquay LD; Cattini PA; Yamagata K; Hanley AJ; Zinman B; Harris SB; Barrett PH; Hegele RA
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4614-9. PubMed ID: 11904371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genes and environment in type 2 diabetes and atherosclerosis in aboriginal Canadians.
    Hegele RA
    Curr Atheroscler Rep; 2001 May; 3(3):216-21. PubMed ID: 11286643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics and type 2 diabetes in youth.
    Gill-Carey O; Hattersley AT
    Pediatr Diabetes; 2007 Dec; 8 Suppl 9():42-7. PubMed ID: 17991132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians.
    Hegele RA; Cao H; Hanley AJ; Zinman B; Harris SB; Anderson CM
    Diabetes Care; 2000 Jun; 23(6):775-8. PubMed ID: 10840995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for the study of the genetic determinants of diabetes and its complications.
    Doria A
    Przegl Lek; 2000; 57 Suppl 3():7-12. PubMed ID: 11293232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender, obesity, hepatic nuclear factor-1alpha G319S and the age-of-onset of type 2 diabetes in Canadian Oji-Cree.
    Hegele RA; Cao H; Harris SB; Zinman B; Hanley AJ; Anderson CM
    Int J Obes Relat Metab Disord; 2000 Aug; 24(8):1062-4. PubMed ID: 10951547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes susceptibility in the Canadian Oji-Cree population is moderated by abnormal mRNA processing of HNF1A G319S transcripts.
    Harries LW; Sloman MJ; Sellers EA; Hattersley AT; Ellard S
    Diabetes; 2008 Jul; 57(7):1978-82. PubMed ID: 18586913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mapping studies of type 2 diabetes mellitus gene in one family].
    Li Y; Lu H; Liu W; Zhang C; Xiong X; Xu S; Huang W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):123-6. PubMed ID: 12673580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the role of common genetic variation in the transient neonatal diabetes mellitus (TNDM) region in type 2 diabetes: a comparative genomic and tagging single nucleotide polymorphism approach.
    Gloyn AL; Mackay DJ; Weedon MN; McCarthy MI; Walker M; Hitman G; Knight BA; Owen KR; Hattersley AT; Frayling TM
    Diabetes; 2006 Aug; 55(8):2272-6. PubMed ID: 16873690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAT2 polymorphism associated with plasma glucose concentration in Canadian Oji-Cree.
    Hegele RA; Kwan K; Harris SB; Hanley AJ; Zinman B; Cao H
    Pharmacogenetics; 2000 Apr; 10(3):233-8. PubMed ID: 10803679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic prediction of coronary heart disease: lessons from Canada.
    Hegele RA
    Scand J Clin Lab Invest Suppl; 1999; 230():153-67. PubMed ID: 10389214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.